TSS
GSK icon

Two Sigma Securities’s GSK GSK Stock Holding History

Two Sigma Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,600
Closed -$669K – 3244
2024
Q1 		$669K Buy
15,600
+4,500
+41% +$186K 0.01% 1375
2023
Q4 		$411K Sell
11,100
-28,600
-72% -$1.03M ﹤0.01% 1703
2023
Q3 		$1.44M Buy
+39,700
New +$1.41M 0.02% 834
2023
Q2 		– Sell
-33,300
Closed -$1.18M – 3002
2023
Q1 		$1.18M Buy
+33,300
New +$1.17M 0.02% 753
2022
Q2 		– Sell
-10,480
Closed -$571K – 2473
2022
Q1 		$571K Buy
+10,480
New +$569K 0.02% 908
2020
Q3 		– Sell
-4,880
Closed -$249K – 1433
2020
Q2 		$249K Buy
+4,880
New +$250K 0.01% 1007
2020
Q1 		– Sell
-5,840
Closed -$343K – 1722
2019
Q4 		$343K Sell
5,840
-29,680
-84% -$1.65M ﹤0.01% 1701
2019
Q3 		$1.9M Buy
35,520
+18,240
+106% +$938K 0.02% 618
2019
Q2 		$864K Buy
17,280
+10,000
+137% +$502K 0.01% 799
2019
Q1 		$380K Sell
7,280
-29,360
-80% -$1.47M ﹤0.01% 1033
2018
Q4 		$1.75M Sell
36,640
-72,880
-67% -$3.59M 0.02% 414
2018
Q3 		$5.5M Sell
109,520
-73,600
-40% -$3.74M 0.04% 348
2018
Q2 		$9.23M Sell
183,120
-13,040
-7% -$657K 0.05% 293
2018
Q1 		$9.58M Buy
+196,160
New +$9.14M 0.05% 294

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Two Sigma Securities's GSK Position: Q2 2025 in Review

Two Sigma Securities sold out of GSK (GSK) in Q2 2025, closing a stake of 7,353 shares — an estimated $285K sold.

Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters. The position peaked at $1.85M in Q2 2023. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Two Sigma Securities reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 7,353 GSK shares in Q2 2025, an estimated $285K.
  • Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters.
  • Two Sigma Securities's GSK position peaked at $1.85M in Q2 2023.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.